BioSpace News Archive

RadNet, Inc. announced that it will host a conference call to discuss its fourth quarter 2019 financial results on Thursday, March 12th, 2020 at 7:30 a.m. Pacific Time.

Maxar Technologies plans to release its fourth quarter 2019 financial results after the market closes on Monday, March 2, 2020.

RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a corporate and financial update for the fourth quarter and full year of 2019 on Wednesday, February 26, 2020 at 4:30 p.m. ET. The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international) and entering the conference code: 4188787. The live and

AUSTIN, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced the initiation of dosing in a Phase I study investigating TAK-169 in patients with relapsed/refractory multiple myel

NEW YORK, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will present a corporate overview at two upcoming investor conferences: SVB Leerink 9 th Annual Global Healthcare Conference , on February 26, 2020 at 9:30 AM Eastern Time. The conference will be he

YARDLEY, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the appointment of Victor M. Clavelli as Chief Commercial Officer. Mr. Clavelli joins Optinose from Pfizer where, in the course of an accomplished 20-year career, he held leadership roles including marketing, sales, and regulatory affairs. Most recently, he served as the North American President f

OLDWICK, N.J. , Feb. 19, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will present at two upcoming conferences: The 9 th Annual SVB Leerink Global Healthcare Conference on Wednes

NEWARK, Calif. , Feb. 19, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that Dinesh V. Patel , Ph.D., President and Chief Executive Officer, will present a corporate overview at the upcoming the SVB Leerink 9th Annual Global Healthcare Conference in New York . Presentation details: Event: SVB Leerink 9th Annual Global Healthcare Confere

Feb. 19, 2020 11:59 UTC Bristol-Myers Squibb to Hold Investor Day on April 2 NEW YORK--( BUSINESS WIRE )-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it will hold an Investor Day in New York City on Thursday, April 2, 2020. Giovanni Caforio, M.D. , chairman and chief executive officer, and members of the leadership team will discuss the Company’s strategy, pipeline and business opportunities. The event will be webcast simultaneously at http://investor.b

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside chat at the 9 th Annual SVB Leerink Global Healthcare Conference. The fireside chat will take place on Wednesda